Global Green Inc.'s Salmonella Vaccine Meets FDA Food Policy

The Salmogenics vaccine is injected into the egg, before the chick is hatched, improving the immune system, health and welfare of the chicken from the first day of age.

Green bio-pharmaceutical company Global Green, Inc., announced this week that their patented Salmonella vaccine for poultry, Salmogenics, meets the FDA's policy of phasing out antibiotics on farms. Studies showed that Salmogenics helped chickens increase in weight without the use of any antibiotics.

The Salmogenics vaccine is injected into the egg, before the chick is hatched, improving the immune system, health and welfare of the chicken from the first day of age, cost-effectively providing a healthier source of protein for humans.

"One of the reasons antibiotics are overused is due to the benefit of the chicken gaining weight. In our studies, we showed Salmogenics can help chickens gain .126 pounds more weight per chicken which is equal to 5 billion 40 million more pounds of chicken worldwide," said Dr. Mehran Ghazvini, DC, NMD, Chairman and CEO. "I believe we have the solution to this problem to help growers meet the FDA requirements to use the antibiotics just to defend against the disease."

The European Food Safety Authority announced that antibiotics have been widely used in animal production for decades worldwide. The Commission decided to phase out, and ultimately ban in 2006 the marketing and use of antibiotics as growth promoters in feed. This decision was based on opinions from the Scientific Steering Committee, which recommended the progressive phasing out of antibiotics used for growth stimulation, while still preserving animal health.

To read more, click HERE.

Latest